179 results on '"Gagliardi, Christian"'
Search Results
2. Correction to: Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy
3. Abstract 4144360: Neurohormonal therapies at baseline and follow-up and survival in patients with wild-type transthyretin cardiac amyloidosis
4. Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy
5. Racial Differences in Atrial Fibrillation Management Between White Patients and Black Patients in Transthyretin Cardiac Amyloid
6. Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
7. Incidence and predictors of sudden death in patients with cardiac amyloidosis.
8. Patisiran for the treatment of patients with p.Ile88Leu hereditary transthyretin amyloidosis: an Italian real-life experience
9. Sino-tubular junction to sinuses of Valsalva ratio: An echocardiographic parameter to predict coronary artery ectasia in patients with aortic enlargement
10. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS
11. Temporal implementation of a regional referral pathway in transthyretin cardiac amyloidosis: Emilia-Romagna experience.
12. Characterization and natural history of different phenotypes in hereditary transthyretin amyloidosis: 40-year experience at a single Italian referral center
13. Familial Cardiac Amyloidoses
14. Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis
15. Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?
16. Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis
17. Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
18. Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis
19. Diagnostic pathways to wild‐type transthyretin amyloid cardiomyopathy: a multicentre network study
20. Screening approaches to cardiac amyloidosis in different clinical settings: Current practice and future perspectives
21. 172 CLINICAL AND PROGNOSTIC IMPLICATIONS OF RV UPTAKE WITH RADIONUCLIDE SCINTIGRAPHY IN TRANSTHYRETIN CARDIAC AMYLOIDOSIS
22. 786 SYSTOLIC ANTERIOR MOVEMENT OF MITRAL VALVE: NOT ONLY HYPERTROPHIC CARDIOMYOPATHY, BUT ALSO CARDIAC AMYLOIDOSIS
23. 826 NEW THERAPEUTIC PERSPECTIVES IN CARDIAC AMYLOIDOSIS
24. Cardiac amyloidosis: the great pretender
25. Systemic embolism in amyloid transthyretin cardiomyopathy
26. Role of 99mTc-DPD Scintigraphy in Diagnosis and Prognosis of Hereditary Transthyretin-Related Cardiac Amyloidosis
27. Assessment of cardiovascular autonomic function in hereditary transthyretin amyloidosis
28. 172 Two mutations, one patient: which phenotype?
29. 334 Hereditary transthyretin amyloidosis: main features and profiles of different clinical phenotypes
30. 199 Lower aortic valve calcium scores by computed tomography scan. A potential new red flag of concomitant cardiac amyloidosis in patients with severe aortic stenosis
31. 351 Prevalence and prognostic significance of RV uptake (biventricular uptake) at planar scintigraphy in patients with ATTR cardiac amyloidosis
32. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis
33. Advanced Heart Failure in a Special Population
34. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy
35. Prevalence, risk factors and correlation with cardiac involvement of carpal tunnel syndrome in amyloidosis
36. Glu89Gln transthyretin-related amyloidosis in Italy and Bulgaria: does geographic area influence phenotype beyond the shared mutation?
37. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis : Insights From THAOS
38. Role of gender in transthyretin-related amyloidosis: an international perspective based on the Transthyretin Amyloid Outcomes Survey (THAOS)
39. Current patterns of beta‐blocker prescription in cardiac amyloidosis: an Italian nationwide survey
40. A new therapy for transthyretin amyloidosis, no longer an orphan condition
41. Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure
42. Role of gender in transthyretin-related amyloidosis: an international perspective based on the Transthyretin Amyloid Outcomes Survey (THAOS)
43. Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies
44. Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis
45. Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths
46. The Authors Reply
47. Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?
48. La cardiomiopatia amiloidotica correlata alla transtiretina: Alla ricerca del trattamento eziologico
49. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role
50. Etiology of Amyloidosis Determines Myocardial 99mTc-DPD Uptake in Amyloidotic Cardiomyopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.